Summit Therapeutics
SMMT
#2244
Rank
A$12.02 B
Marketcap
A$15.03
Share price
-5.87%
Change (1 day)
-40.03%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: A$12.02 Billion

As of November 2026 Summit Therapeutics has a market cap of A$12.02 Billion. This makes Summit Therapeutics the world's 2244th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026A$12.02 B-40.37%
2025A$20.16 B-6.62%
2024A$21.58 B704.13%
2023A$2.68 B113.54%
2022A$1.25 B246.79%
2021A$0.36 B-27.89%
2020A$0.50 B227.52%
2019A$0.15 B471.59%
2018A$26.85 M-87.32%
2017A$0.21 B45.06%
2016A$0.14 B-24.54%
2015A$0.19 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Summit Therapeutics was reported to be:

A$12.02 Billion
by Nasdaq info icon info icon
A$12.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
A$2.15 B-82.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
A$0.33 B-97.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
A$86.33 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
A$9.31 B-22.52%๐Ÿ‡บ๐Ÿ‡ธ USA